Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneovenous shunts for malignant ascites.

T Sonnenfeld, G Tydén

    Acta Chirurgica Scandinavica
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Peritoneovenous shunts effectively managed malignant ascites in 27 patients, offering good palliation and enabling many to return home. While survival was limited by terminal cancer, shunting provided significant symptom relief.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Autotransplantation for renovascular hypertension in children with solitary functioning kidney.

    Journal of human hypertension·2012
    Same author

    Is rituximab safe to use in kidney transplant patients?

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2010
    Same author

    Introduction of hand-assisted retroperitoneoscopic living donor nephrectomy at Karolinska University Hospital Huddinge.

    Transplantation proceedings·2006
    Same author

    Pharmacodynamics of rituximab in kidney allotransplantation.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
    Same author

    ABO-incompatible kidney transplantation and rituximab.

    Transplantation proceedings·2005
    Same author

    Refractory acute renal allograft rejection successfully treated with photopheresis.

    Transplantation proceedings·2005
    Same journal

    Uretero-intestinal implantation according to Coffey.

    Acta chirurgica Scandinavica·2010
    Same journal

    Closure of the bronchus in pneumonectomy and lobectomy.

    Acta chirurgica Scandinavica·2010
    Same journal

    Tables for calculation of exact measurements of radiographed objects.

    Acta chirurgica Scandinavica·2010
    Same journal

    Treatment of the congenital flat-foot.

    Acta chirurgica Scandinavica·2010
    Same journal

    On the practical importance of the clinical determination of the basal metabolic rate in thyrotoxicosis.

    Acta chirurgica Scandinavica·2010
    Same journal

    Splanchnectomy by megacolon congenitum.

    Acta chirurgica Scandinavica·2010
    See all related articles

    Area of Science:

    • Oncology
    • Surgical Procedures
    • Palliative Care

    Background:

    • Malignant ascites presents a significant challenge in advanced cancer care.
    • Intractable fluid accumulation severely impacts patient quality of life.

    Purpose of the Study:

    • To evaluate the efficacy and safety of peritoneovenous shunting for malignant ascites.
    • To assess the palliative benefits and complication rates of shunt insertion.

    Main Methods:

    • Retrospective analysis of 27 patients with malignant ascites treated with peritoneovenous shunts (Le Veen and Denver types).
    • Procedures performed under local anesthesia.
    • Monitoring for shunt function, complications, and patient outcomes.

    Main Results:

    Related Experiment Videos

    • Good palliation was achieved in patients with functioning shunts.
    • 16 patients were discharged home, experiencing improved comfort.
    • Shunt occlusion occurred in 8 patients, with successful management in some cases.
    • All patients died within 4 months due to terminal malignancy.

    Conclusions:

    • Peritoneovenous shunting offers effective palliation for selected patients with malignant ascites.
    • The procedure is safe when performed under local anesthesia.
    • Careful patient selection is crucial for optimal outcomes.